ArQule Stock Price - ARQL

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
ArQule Inc ARQL NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.145 1.87% 7.905 8.00 7.78 7.78 7.76 11:44:42
Bid Price Ask Price Spread Spread % News
7.90 7.91 0.01 0.13% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,053 790,104 $ 7.89 $ 6,235,854 2,216,338 2.23 - 12.22
Last Trade Time Type Quantity Stock Price Currency
11:44:59 100 $ 7.905 USD

ArQule Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 959.83M 120.73M $ -15.48M -0.16 - 118.78M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

ArQule News

Loading Messages....

Latest ARQL Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARQL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week8.058.06187.367.672,177,502-0.145-1.8%
1 Month9.1510.506.988.752,083,067-1.25-13.61%
3 Months9.5310.506.798.402,075,621-1.63-17.05%
6 Months6.2912.225.838.922,631,4061.6225.68%
1 Year3.7012.222.237.521,984,6724.21113.65%
3 Years1.3912.220.91696.131,090,2006.52468.71%
5 Years1.2012.220.91695.63739,8366.71558.75%

ArQule Description

Arqule Inc is a biopharmaceutical company, engaged in the research and development of therapeutics to treat cancers and rare diseases. The objective of the company is to discover, develop and commercialize novel small molecule drugs in areas of high unmet need that will dramatically extend and improve the lives of the patients. These drugs focus on the biological pathways implicated in a range of cancers and certain non-oncology indications. Geographically, the firm operates through the region of United States.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.